Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Ho

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Antibody Therapeutics|March 3, 2020
Ancient species offers contemporary therapeutics: an update on shark V<sub>NAR</sub> single domain antibody sequences, phage libraries and potential clinical applicationsHejiao English, Jessica Hong, Mitchell Ho
Anti-Cancer Agents in Medicinal Chemistry|June 23, 2012
The role of mesothelin in tumor progression and targeted therapyZhewei Tang, Min Qian, Mitchell Ho
Plos One|November 22, 2013
Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude miceHeungnam Kim, Wei Gao, Mitchell Ho
Plos One|June 28, 2012
Changes in global gene expression associated with 3D structure of tumors: an ex vivo matrix-free mesothelioma spheroid modelHeungnam Kim, Yen Phung, Mitchell Ho
Mabs|August 7, 2012
2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USAMitchell Ho, Ivor Royston, Alain Beck
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 7, 2020
The Role of Glypicans in Cancer Progression and TherapyNan Li, Madeline R Spetz, Mitchell Ho
Scientific Reports|May 18, 2016
Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfateWei Gao, Yongmei Xu, Jian Liu, et al.
Current Protocols|June 17, 2022
Production and Purification of Shark and Camel Single-Domain Antibodies from Bacterial and Mammalian Cell Expression SystemsZhijian Duan, Jesse Buffington, Jessica Hong, et al.
Advances in Cancer Research|August 12, 2022
Immunotherapy for hepatobiliary cancers: Emerging targets and translational advancesDan Li, Shaoli Lin, Jessica Hong, et al.
International Journal of Cancer|July 10, 2010
Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitroMingqian Feng, Heungnam Kim, Yen Phung, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Antibody Therapeutics|March 3, 2020
Ancient species offers contemporary therapeutics: an update on shark V<sub>NAR</sub> single domain antibody sequences, phage libraries and potential clinical applicationsHejiao English, Jessica Hong, Mitchell Ho
Anti-Cancer Agents in Medicinal Chemistry|June 23, 2012
The role of mesothelin in tumor progression and targeted therapyZhewei Tang, Min Qian, Mitchell Ho
Plos One|November 22, 2013
Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude miceHeungnam Kim, Wei Gao, Mitchell Ho
Plos One|June 28, 2012
Changes in global gene expression associated with 3D structure of tumors: an ex vivo matrix-free mesothelioma spheroid modelHeungnam Kim, Yen Phung, Mitchell Ho
Mabs|August 7, 2012
2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USAMitchell Ho, Ivor Royston, Alain Beck
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 7, 2020
The Role of Glypicans in Cancer Progression and TherapyNan Li, Madeline R Spetz, Mitchell Ho
Scientific Reports|May 18, 2016
Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfateWei Gao, Yongmei Xu, Jian Liu, et al.
Current Protocols|June 17, 2022
Production and Purification of Shark and Camel Single-Domain Antibodies from Bacterial and Mammalian Cell Expression SystemsZhijian Duan, Jesse Buffington, Jessica Hong, et al.
Advances in Cancer Research|August 12, 2022
Immunotherapy for hepatobiliary cancers: Emerging targets and translational advancesDan Li, Shaoli Lin, Jessica Hong, et al.
International Journal of Cancer|July 10, 2010
Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitroMingqian Feng, Heungnam Kim, Yen Phung, et al.
Pageof 15